PTP Accounts Production v23.1.5.20 13831834 director 1.2.23 31.1.24 31.1.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh138318342023-01-31138318342024-01-31138318342023-02-012024-01-31138318342022-01-05138318342022-01-062023-01-31138318342023-01-3113831834ns15:EnglandWales2023-02-012024-01-3113831834ns14:PoundSterling2023-02-012024-01-3113831834ns10:Director12023-02-012024-01-3113831834ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3113831834ns10:SmallEntities2023-02-012024-01-3113831834ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3113831834ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3113831834ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3113831834ns10:FullAccounts2023-02-012024-01-3113831834ns10:OrdinaryShareClass12023-02-012024-01-3113831834ns10:RegisteredOffice2023-02-012024-01-3113831834ns5:CurrentFinancialInstruments2024-01-3113831834ns5:CurrentFinancialInstruments2023-01-3113831834ns5:ShareCapital2024-01-3113831834ns5:ShareCapital2023-01-3113831834ns5:RetainedEarningsAccumulatedLosses2024-01-3113831834ns5:RetainedEarningsAccumulatedLosses2023-01-3113831834ns5:FurnitureFittings2023-02-012024-01-3113831834ns5:FurnitureFittings2023-01-3113831834ns5:FurnitureFittings2024-01-3113831834ns5:FurnitureFittings2023-01-3113831834ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-3113831834ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-3113831834ns10:OrdinaryShareClass12024-01-3113831834ns5:RetainedEarningsAccumulatedLosses2023-01-3113831834ns5:RetainedEarningsAccumulatedLosses2023-02-012024-01-31
REGISTERED NUMBER: 13831834 (England and Wales)















Financial Statements for the Year Ended 31 January 2024

for

ASK PHARM LTD

ASK PHARM LTD (Registered number: 13831834)






Contents of the Financial Statements
for the Year Ended 31 January 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


ASK PHARM LTD

Company Information
for the Year Ended 31 January 2024







DIRECTOR: A P S Nagra





REGISTERED OFFICE: 457 Wolverhampton Road
Oldbury
West Midlands
B68 8DD





REGISTERED NUMBER: 13831834 (England and Wales)





ACCOUNTANTS: Aggarwal & Co
Chartered Certified Accountants
471 Green Lane
Coventry
West Midlands
CV3 6EL

ASK PHARM LTD (Registered number: 13831834)

Balance Sheet
31 January 2024

31.1.24 31.1.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,613 2,016

CURRENT ASSETS
Debtors 5 25,550 19,064
Cash at bank and in hand 580 2,907
26,130 21,971
CREDITORS
Amounts falling due within one year 6 7,558 5,702
NET CURRENT ASSETS 18,572 16,269
TOTAL ASSETS LESS CURRENT
LIABILITIES

20,185

18,285

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 8 20,085 18,185
SHAREHOLDERS' FUNDS 20,185 18,285

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 23 July 2024 and were signed by:





A P S Nagra - Director


ASK PHARM LTD (Registered number: 13831834)

Notes to the Financial Statements
for the Year Ended 31 January 2024

1. STATUTORY INFORMATION

ASK PHARM LTD is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures, fittings & equipment - 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

ASK PHARM LTD (Registered number: 13831834)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

4. TANGIBLE FIXED ASSETS
Fixtures,
fittings
& equipmen
£   
COST
At 1 February 2023
and 31 January 2024 2,520
DEPRECIATION
At 1 February 2023 504
Charge for year 403
At 31 January 2024 907
NET BOOK VALUE
At 31 January 2024 1,613
At 31 January 2023 2,016

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Trade debtors 4,235 5,520
Other debtors 21,315 13,544
25,550 19,064

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Trade creditors - 1
Taxation and social security 6,404 4,788
Other creditors 1,154 913
7,558 5,702

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.24 31.1.23
value: £    £   
100 Ordinary £1 100 100

ASK PHARM LTD (Registered number: 13831834)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

8. RESERVES
Retained
earnings
£   

At 1 February 2023 18,185
Profit for the year 26,900
Dividends (25,000 )
At 31 January 2024 20,085

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The directors overdrawn loan account is charged at official interest rate. The loan was repaid shortly after the year end.